TAG Episode 31 - 6Jun2019 LEWIS Rick Rho Kinase Inhibitors: a new class of drugs (AAC)

TAG Episode 31 - 6Jun2019 LEWIS Rick Rho Kinase Inhibitors: a new class of drugs (AAC)

The goal of the late Dave Epstein was to find a drug that treats the cause of glaucoma by improving trabecular meshwork outflow. After many years of research, Aerie Pharmaceuticals was formed and refined a Rho Kinase inhibitor called Netarsudil. In April 2018 this came to market as Rhopressa and March 2019, combined with latanoprost, as Roclatan. Today I’m talking with Rick Lewis, a glaucoma colleague based in Sacramento and Chief Medical Officer for Aerie Pharmaceuticals…and we’re Talking About Glaucoma.

Read More

TAG Episode 30 - 5Nov2018 JOHNSTONE Murray Pulsatile Flow (AAC)

TAG Episode 30 - 5Nov2018 JOHNSTONE Murray Pulsatile Flow (AAC)

In this episode, I talk with Murray Johnstone from Seattle about pulsatile flow through the Trabecular Meshwork and collector channels. We discuss the imaging improvements over the years that have made this possible including the latest phase-based OCT scans that result in nanometre resolution instead of the micrometre resolution of spectral domain scans that most of us are using  in clinical practice.

Read More

TAG Episode 26 - 29Jan2017: Wright Tx to Outcome Gap (AAC enhanced)

TAG Episode 26 - 29Jan2017: Wright Tx to Outcome Gap (AAC enhanced)

In this episode, I talk with Tracy Wright, now based at Kaiser Permanente in Washington DC. He was at the Bascom Palmer Eye Institute at the University of Miami when we recorded this conversation. The implications immediately effected how I look at visual fields. The findings you are about to here may be shocking...

Read More